What is Everything Genetic?
Everything Genetic operates as a pivotal distributor of genetic cancer testing services, bridging the gap between complex genomic data and actionable clinical outcomes. The company provides a comprehensive suite of services, including risk assessment, diagnostic testing, and prognostic evaluation. By catering to a diverse clientele—ranging from healthcare providers and corporate employers to individual patients—the firm facilitates a proactive approach to oncology management. Their business model is built upon the foundation of disease prevention, supported by rigorous pre- and post-test clinical guidance that ensures patients and providers can navigate genetic insights with precision and confidence. As a leader in the UK market, Everything Genetic remains committed to democratizing access to affordable, high-quality diagnostic tools that are essential for modern personalized medicine.
How much funding has Everything Genetic raised?
Everything Genetic has raised a total of $6.3M across 1 funding round:
Debt
$6.3M
Debt (2022): $6.3M with participation from TradePlus24
Key Investors in Everything Genetic
TradePlus24
A specialized financial services firm providing innovative debt financing solutions to support the growth and working capital requirements of expanding enterprises.
What's next for Everything Genetic?
With the recent infusion of capital, Everything Genetic is strategically positioned to scale its operational infrastructure and enhance its service delivery model. The company is expected to focus on deepening its market penetration among enterprise employers who are increasingly prioritizing proactive health management as a core component of their employee benefits packages. Furthermore, the firm will likely invest in expanding its diagnostic portfolio, ensuring that its clinical-grade offerings remain at the cutting edge of oncological research. By maintaining a focus on accessibility and clinical support, Everything Genetic is well-equipped to navigate the evolving landscape of genomic healthcare, driving long-term value for stakeholders while improving patient outcomes through early detection and informed decision-making.
See full Everything Genetic company page
